Recent studies indicated that single nucleotide polymorphisms in genes of cell cycle pathway and NF-κB pathway can potentially predict the clinical responses to radiotherapy for NPC patients [11]. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.